FDA sees 50% increase in Form 2253 submissions

Share this article:
There has been a 50% increase to 61,000 in FDA Form 2253s submitted with promotional pieces during the past four years to the FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC). Of these, 43,000 pieces were professional ads, and almost 11,000 were DTC.
Share this article:
close

Next Article in News

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.